The effect of cilgavimab and neutralisation by vaccine-induced antibodies in emerging SARS-CoV-2 BA.4 and BA.5 sublineages
Prerna Arora, Lu Zhang, Inga Nehlmeier, Amy Kempf, Anne Cossmann, Alexandra Dopfer‐Jablonka, Sebastian Schulz, Hans‐Martin Jäck, Georg M. N. Behrens, Stefan Pöhlmann, Markus Hoffmann
Topics & Concepts
NeutralizationVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Antibody2019-20 coronavirus outbreakBiologyMedicineImmunologyVirusOutbreakInfectious disease (medical specialty)DiseasePathologySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesRetinal and Optic Conditions